CHAMPIONS ONCOLOGY, INC. Research and Development Expense
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Research and Development Expense of $2.34 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. research and development expense for the quarter ending 2026-07-31 was $2.34M, a 12.58% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. research and development expense for the quarter ending 2026-04-30 was $2.12M, a 7.74% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. research and development expense for the quarter ending 2026-01-31 was $2.27M, a 32.11% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. research and development expense for the quarter ending 2025-10-31 was $2.62M, a 54.88% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. research and development expense for fiscal 2026 was $9.08M, a 33.10% increase from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. research and development expense for fiscal 2025 was $6.83M, a 28.49% decline from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. research and development expense for fiscal 2024 was $9.54M, a 17.33% decline from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. research and development expense for fiscal 2023 was $11.54M, a 23.16% increase from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-07-31 | $2.34M 10-Q · filed 2026-09-11 | $4.46M derived: sum of 2 quarters · filed 2026-09-11 | $6.73M derived: sum of 3 quarters · filed 2026-09-11 | $9.35M derived: sum of 4 quarters · filed 2026-09-11 |
| 2026-04-30 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $4.39M derived: sum of 2 quarters · filed 2026-07-27 | $7.00M derived: sum of 3 quarters · filed 2026-07-27 | $9.08M 10-K · filed 2026-07-27 |
| 2026-01-31 | $2.27M 10-Q · filed 2026-03-12 | $4.89M derived: sum of 2 quarters · filed 2026-03-12 | $6.97M 10-Q · filed 2026-03-12 | $8.93M derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-10-31 | $2.62M 10-Q · filed 2025-12-15 | $4.70M 10-Q · filed 2025-12-15 | $6.66M derived: sum of 3 quarters · filed 2026-09-11 | $8.38M derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-07-31 | $2.08M 10-Q · filed 2026-09-11 | $4.04M derived: sum of 2 quarters · filed 2026-09-11 | $5.76M derived: sum of 3 quarters · filed 2026-09-11 | $7.45M derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-04-30 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $3.68M derived: sum of 2 quarters · filed 2026-07-27 | $5.37M derived: sum of 3 quarters · filed 2026-07-27 | $6.83M 10-K · filed 2026-07-27 |
| 2025-01-31 | $1.72M 10-Q · filed 2026-03-12 | $3.41M derived: sum of 2 quarters · filed 2026-03-12 | $4.86M 10-Q · filed 2026-03-12 | $6.91M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-10-31 | $1.69M 10-Q · filed 2025-12-15 | $3.14M 10-Q · filed 2025-12-15 | $5.19M derived: sum of 3 quarters · filed 2025-12-15 | $7.38M derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | $1.45M 10-Q · filed 2025-09-15 | $3.50M derived: sum of 2 quarters · filed 2025-09-15 | $5.69M derived: sum of 3 quarters · filed 2025-09-15 | $8.21M derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | $4.24M derived: sum of 2 quarters · filed 2025-07-23 | $6.75M derived: sum of 3 quarters · filed 2025-07-23 | $9.54M 10-K · filed 2025-07-23 |
| 2024-01-31 | $2.19M 10-Q · filed 2025-03-17 | $4.70M derived: sum of 2 quarters · filed 2025-03-17 | $7.49M 10-Q · filed 2025-03-17 | $10.35M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | $2.52M 10-Q · filed 2024-12-16 | $5.31M 10-Q · filed 2024-12-16 | $8.16M derived: sum of 3 quarters · filed 2024-12-16 | $11.36M derived: sum of 4 quarters · filed 2024-12-16 |
| 2023-07-31 | $2.79M 10-Q · filed 2024-09-13 | $5.64M derived: sum of 2 quarters · filed 2024-09-13 | $8.85M derived: sum of 3 quarters · filed 2024-09-13 | $11.45M derived: sum of 4 quarters · filed 2024-09-13 |
| 2023-04-30 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19 | $6.05M derived: sum of 2 quarters · filed 2024-07-19 | $8.66M derived: sum of 3 quarters · filed 2024-07-19 | $11.54M 10-K · filed 2024-07-19 |
| 2023-01-31 | $3.20M 10-Q · filed 2024-03-15 | $5.81M derived: sum of 2 quarters · filed 2024-03-15 | $8.69M 10-Q · filed 2024-03-15 | $11.28M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-10-31 | $2.60M 10-Q · filed 2023-12-13 | $5.49M 10-Q · filed 2023-12-13 | $8.08M derived: sum of 3 quarters · filed 2023-12-13 | $10.26M derived: sum of 4 quarters · filed 2023-12-13 |
| 2022-07-31 | $2.89M 10-Q · filed 2023-09-13 | $5.48M derived: sum of 2 quarters · filed 2023-09-13 | $7.66M derived: sum of 3 quarters · filed 2023-09-13 | $9.96M derived: sum of 4 quarters · filed 2023-09-13 |
| 2022-04-30 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24 | $4.77M derived: sum of 2 quarters · filed 2023-07-24 | $7.07M derived: sum of 3 quarters · filed 2023-07-24 | $9.37M 10-K · filed 2023-07-24 |
| 2022-01-31 | $2.18M 10-Q · filed 2023-03-16 | $4.48M derived: sum of 2 quarters · filed 2023-03-16 | $6.78M 10-Q · filed 2023-03-16 | $8.86M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-10-31 | $2.30M 10-Q · filed 2022-12-13 | $4.60M 10-Q · filed 2022-12-13 | $6.67M derived: sum of 3 quarters · filed 2022-12-13 | $8.55M derived: sum of 4 quarters · filed 2022-12-13 |
| 2021-07-31 | $2.30M 10-Q · filed 2022-09-12 | $4.38M derived: sum of 2 quarters · filed 2022-09-12 | $6.25M derived: sum of 3 quarters · filed 2022-09-12 | $7.90M derived: sum of 4 quarters · filed 2022-09-12 |
| 2021-04-30 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $3.95M derived: sum of 2 quarters · filed 2022-07-22 | $5.60M derived: sum of 3 quarters · filed 2022-07-22 | $7.20M 10-K · filed 2022-07-22 |
| 2021-01-31 | $1.88M 10-Q · filed 2022-03-15 | $3.53M derived: sum of 2 quarters · filed 2022-03-15 | $5.13M 10-Q · filed 2022-03-15 | $6.94M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | $1.65M 10-Q · filed 2021-12-13 | $3.25M 10-Q · filed 2021-12-13 | $5.07M derived: sum of 3 quarters · filed 2021-12-13 | $6.46M derived: sum of 4 quarters · filed 2021-12-13 |
| 2020-07-31 | $1.60M 10-Q · filed 2021-09-13 | $3.42M derived: sum of 2 quarters · filed 2021-09-13 | $4.81M derived: sum of 3 quarters · filed 2021-09-13 | $6.15M derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-04-30 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $3.21M derived: sum of 2 quarters · filed 2021-07-26 | $4.55M derived: sum of 3 quarters · filed 2021-07-26 | $5.85M 10-K · filed 2021-07-26 |
| 2020-01-31 | $1.39M 10-Q · filed 2021-03-15 | $2.73M derived: sum of 2 quarters · filed 2021-03-15 | $4.04M 10-Q · filed 2021-03-15 | $5.28M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-10-31 | $1.34M 10-Q · filed 2020-12-14 | $2.64M 10-Q · filed 2020-12-14 | $3.89M derived: sum of 3 quarters · filed 2020-12-14 | $5.16M derived: sum of 4 quarters · filed 2020-12-14 |
| 2019-07-31 | $1.30M 10-Q · filed 2020-09-14 | $2.55M derived: sum of 2 quarters · filed 2020-09-14 | $3.82M derived: sum of 3 quarters · filed 2020-09-14 | $5.01M derived: sum of 4 quarters · filed 2020-09-14 |
| 2019-04-30 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | $2.52M derived: sum of 2 quarters · filed 2020-07-28 | $3.71M derived: sum of 3 quarters · filed 2020-07-28 | $4.80M 10-K · filed 2020-07-28 |
| 2019-01-31 | $1.27M 10-Q · filed 2020-03-16 | $2.46M derived: sum of 2 quarters · filed 2020-03-16 | $3.55M 10-Q · filed 2020-03-16 | $4.64M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-10-31 | $1.19M 10-Q · filed 2019-12-16 | $2.28M 10-Q · filed 2019-12-16 | $3.37M derived: sum of 3 quarters · filed 2019-12-16 | $4.42M derived: sum of 4 quarters · filed 2019-12-16 |
| 2018-07-31 | $1.09M 10-Q · filed 2019-09-16 | $2.18M derived: sum of 2 quarters · filed 2019-09-16 | $3.23M derived: sum of 3 quarters · filed 2019-09-16 | $4.34M derived: sum of 4 quarters · filed 2019-09-16 |
| 2018-04-30 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | $2.14M derived: sum of 2 quarters · filed 2019-07-29 | $3.25M derived: sum of 3 quarters · filed 2019-07-29 | $4.40M 10-K · filed 2019-07-29 |
| 2018-01-31 | $1.04M 10-Q · filed 2019-03-18 | $2.16M derived: sum of 2 quarters · filed 2019-03-18 | $3.31M 10-Q · filed 2019-03-18 | $4.35M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-10-31 | $1.11M 10-Q · filed 2018-12-17 | $2.23M 10-Q · filed 2018-12-17 | $3.31M derived: sum of 3 quarters · filed 2018-12-17 | $4.31M derived: sum of 4 quarters · filed 2018-12-17 |
| 2017-07-31 | $1.12M 10-Q · filed 2018-09-14 | $2.19M derived: sum of 2 quarters · filed 2018-09-14 | $3.19M derived: sum of 3 quarters · filed 2018-09-14 | $4.20M derived: sum of 4 quarters · filed 2018-09-14 |
| 2017-04-30 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $2.07M derived: sum of 2 quarters · filed 2018-07-30 | $3.08M derived: sum of 3 quarters · filed 2018-07-30 | $4.29M 10-K · filed 2018-07-30 |
| 2017-01-31 | $998.00K 10-Q · filed 2018-03-19 | $2.01M derived: sum of 2 quarters · filed 2018-03-19 | $3.22M 10-Q · filed 2018-03-19 | $4.39M derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | $1.01M 10-Q · filed 2017-12-15 | $2.22M 10-Q · filed 2017-12-15 | $3.40M derived: sum of 3 quarters · filed 2017-12-15 | $4.39M derived: sum of 4 quarters · filed 2017-12-15 |
| 2016-07-31 | $1.21M 10-Q · filed 2017-09-14 | $2.39M derived: sum of 2 quarters · filed 2017-09-14 | $3.39M derived: sum of 3 quarters · filed 2017-09-14 | $4.30M derived: sum of 4 quarters · filed 2017-09-14 |
| 2016-04-30 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $2.17M derived: sum of 2 quarters · filed 2017-07-28 | $3.09M derived: sum of 3 quarters · filed 2017-07-28 | $4.19M 10-K · filed 2017-07-28 |
| 2016-01-31 | $999.00K 10-Q · filed 2017-03-17 | $1.92M derived: sum of 2 quarters · filed 2017-03-17 | $3.02M 10-Q · filed 2017-03-17 | $4.11M derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-10-31 | $919.00K 10-Q · filed 2016-12-14 | $2.02M 10-Q · filed 2016-12-14 | $3.11M derived: sum of 3 quarters · filed 2016-12-14 | $4.20M derived: sum of 4 quarters · filed 2016-12-14 |
| 2015-07-31 | $1.10M 10-Q · filed 2016-09-14 | $2.19M derived: sum of 2 quarters · filed 2016-09-14 | $3.28M derived: sum of 3 quarters · filed 2016-09-14 | $4.53M derived: sum of 4 quarters · filed 2016-09-14 |
| 2015-04-30 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $2.18M derived: sum of 2 quarters · filed 2016-07-29 | $3.43M derived: sum of 3 quarters · filed 2016-07-29 | $4.84M 10-K · filed 2016-07-29 |
| 2015-01-31 | $1.09M 10-Q · filed 2016-03-16 | $2.34M derived: sum of 2 quarters · filed 2016-03-16 | $3.76M 10-Q · filed 2016-03-16 | $4.42M derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-10-31 | $1.25M 10-Q · filed 2015-12-15 | $2.66M 10-Q · filed 2015-12-15 | $3.32M derived: sum of 3 quarters · filed 2015-12-15 | $3.86M derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | $1.42M 10-Q · filed 2015-09-11 | $2.07M derived: sum of 2 quarters · filed 2015-09-11 | $2.61M derived: sum of 3 quarters · filed 2015-09-11 | $3.29M derived: sum of 4 quarters · filed 2015-09-11 |
| 2014-04-30 | $651.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | $1.19M derived: sum of 2 quarters · filed 2015-07-29 | $1.86M derived: sum of 3 quarters · filed 2015-07-29 | $2.27M 10-K · filed 2015-07-29 |
| 2014-01-31 | $535.00K 10-Q · filed 2015-03-17 | $1.21M derived: sum of 2 quarters · filed 2015-03-17 | $1.61M 10-Q · filed 2015-03-17 | $2.12M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-10-31 | $677.00K 10-Q · filed 2014-12-15 | $1.08M 10-Q · filed 2014-12-15 | $1.58M derived: sum of 3 quarters · filed 2014-12-15 | $2.18M derived: sum of 4 quarters · filed 2014-12-15 |
| 2013-07-31 | $402.00K 10-Q · filed 2014-09-12 | $907.00K derived: sum of 2 quarters · filed 2014-09-12 | $1.50M derived: sum of 3 quarters · filed 2014-09-12 | $1.94M derived: sum of 4 quarters · filed 2014-09-12 |
| 2013-04-30 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | $1.10M derived: sum of 2 quarters · filed 2014-07-28 | $1.53M derived: sum of 3 quarters · filed 2014-07-28 | $1.92M 10-K · filed 2014-07-28 |
| 2013-01-31 | $592.00K 10-Q · filed 2014-03-14 | $1.03M derived: sum of 2 quarters · filed 2014-03-14 | $1.42M 10-Q · filed 2014-03-14 | $1.79M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-10-31 | $436.00K 10-Q · filed 2013-12-13 | $823.00K 10-Q · filed 2013-12-13 | $1.20M derived: sum of 3 quarters · filed 2013-12-13 | $2.13M derived: sum of 4 quarters · filed 2013-12-13 |
| 2012-07-31 | $387.00K 10-Q · filed 2013-09-13 | $766.00K derived: sum of 2 quarters · filed 2013-09-13 | $1.70M derived: sum of 3 quarters · filed 2013-09-13 | $2.70M derived: sum of 4 quarters · filed 2013-09-13 |
| 2012-04-30 | $379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | $1.31M derived: sum of 2 quarters · filed 2013-07-26 | $2.32M derived: sum of 3 quarters · filed 2013-07-26 | $2.94M 10-K · filed 2013-07-26 |
| 2012-01-31 | $930.00K 10-Q · filed 2013-03-13 | $1.94M derived: sum of 2 quarters · filed 2013-03-13 | $2.56M 10-Q · filed 2013-03-13 | $3.27M derived: sum of 4 quarters · filed 2013-03-13 |
| 2011-10-31 | $1.01M 10-Q · filed 2012-12-13 | $1.62M 10-Q · filed 2012-12-13 | $2.34M derived: sum of 3 quarters · filed 2012-12-13 | $2.78M derived: sum of 4 quarters · filed 2012-12-13 |
| 2011-07-31 | $541.00K 10-Q · filed 2012-09-12 | $1.33M derived: sum of 2 quarters · filed 2012-09-12 | $1.77M derived: sum of 3 quarters · filed 2012-09-12 | $2.44M derived: sum of 4 quarters · filed 2012-09-12 |
| 2011-04-30 | $793.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $1.23M derived: sum of 2 quarters · filed 2012-07-18 | $1.90M derived: sum of 3 quarters · filed 2012-07-18 | $2.91M 10-K · filed 2012-07-18 |
| 2011-01-31 | $434.00K 10-Q · filed 2012-03-14 | $1.11M derived: sum of 2 quarters · filed 2012-03-14 | $2.12M 10-Q · filed 2012-03-14 | |
| 2010-10-31 | $673.00K 10-Q · filed 2011-12-14 | $1.50M 10-Q · filed 2011-12-14 | ||
| 2010-07-31 | $919.00K 10-Q · filed 2011-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |